Home

 Home / Therapeutic Experience
No. Therapeutic area Title of study Phase of Trial No. of patients Duration Regulatory
1. Gastroenterology Glutathione in Alcoholic Liver disease III 200 8 months DCGI
2. Cardiovascular Telmisartan + Amlodipine + HCTZ tablets in Hypertensive patients III 210 10 months DCGI
3. Heparin Inj in deep vein thrombosis IV 120 4 Months Kazhkhistan & Colombia
4. Weight management Kionutrime in weight management IV 90 6 Months Marketing
5. Anti.malarial α β – Arteether Injection in Falsiparum Malaria III 220 3 months DCGI
6. Pain management Diclofenac gel in joint pain and muscle sprain IV 100 2.5 months Marketing
7. Paracetamol 1000 mg SR tablets IV 800 9 months PMS
8. Synvisc in pain management IV 30 2 Years Follow up RWLP
9. Anti-aging & Quality of life Nutraceutical product Natural Fruit juice with synthetic analogue of Growth hormone (Placebo controlled trial for USA based client) III 75 7.5 months Currently marketed in UK & Japan
10. Anemia Iron Preparation in female pregnant patients with anaemia IV 60 1.5 Months Marketing
11. r-Erythropoetin Injection in anaemia with chronic renal failure III 120 1 year DCG
12. Dermatology β – Glucan in Psoriasis II 10 4 Months
13. Aphthofix in mouth ulcer II 20 1.5 Months
14. Heelfix and Fingurefix in heel cracks & figure cracks II 30 3 Months Medical Device
15. Permethrine cream in Scabis Double blind placebo controlled trial III 80 6 Months UK MHRA
16. Dental Periocream in root scaling and planning II 30 1 month Medical device
17. Oncology Luprolide in Prostate cancer I 20 + 60 + 30 PK for US FDA
18. Psychiatry Risperidone in Schizophrenic patients I 42 + 36 PK for EU and US